Showing results (1901-1910 of 3,978) with videos related to

Sort By:
Pageof 398
European Journal of Heart Failure|December 22, 2023
Real-world candidacy to mavacamten in a contemporary hypertrophic obstructive cardiomyopathy populationEdoardo Bertero, Chiara Chiti, Maria Alessandra Schiavo, et al.
European Journal of Heart Failure|November 22, 2023
Impact of vasodilators on diuretic response in patients with congestive heart failure: A mechanistic trial of cimlanod (BMS-986231)Pierpaolo Pellicori, John G F Cleland, Maria Borentain, et al.
European Journal of Heart Failure|January 18, 2024
The effect of sodium-glucose cotransporter 2 inhibitors on left cardiac remodelling in heart failure with reduced ejection fraction: Systematic review and meta-analysisMuhammad Shariq Usman, James L Januzzi, Stefan D Anker, et al.
European Journal of Heart Failure|December 7, 2023
Risk of readmission and death after hospitalization for worsening heart failure: Role of post-discharge follow-up visits in a real-world study from the Grand Est Region of FranceGuillaume Baudry, Ouarda Pereira, Kévin Duarte, et al.
European Journal of Heart Failure|March 15, 2024
Sodium-glucose cotransporter 2 inhibitors for transthyretin amyloid cardiomyopathy: Analyses of short-term efficacy and safetyFrederick M Lang, Sergio Teruya, Ariel Weinsaft, et al.
European Journal of Heart Failure|March 6, 2024
Blood pressure and intensive treatment up-titration after acute heart failure hospitalization: Insights from the STRONG-HF trialMatteo Pagnesi, Oscar Alberto Gomez Vilamajó, Alejandro Meiriño, et al.
European Journal of Heart Failure|March 15, 2024
Dapagliflozin in patients with heart failure and previous myocardial infarction: A participant-level pooled analysis of DAPA-HF and DELIVERAlexander Peikert, Muthiah Vaduganathan, Brian L Claggett, et al.
European Journal of Heart Failure|March 7, 2024
Diuretic use and outcomes in patients with heart failure with reduced ejection fraction: Insights from the VICTORIA trialJustin Ezekowitz, Wendimagegn Alemayehu, Frank Edelmann, et al.
European Journal of Heart Failure|March 5, 2024
Effect of long-term tafamidis treatment on health-related quality of life in patients with transthyretin amyloid cardiomyopathyMartha Grogan, Margot K Davis, Maria G Crespo-Leiro, et al.
European Journal of Heart Failure|April 8, 2024
Effects of sacubitril/valsartan according to polypharmacy status in PARAGON-HFShingo Matsumoto, Mingming Yang, Li Shen, et al.
Pageof 398